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Summary
Objective: In this study, we were interested in the overall methylation level in aged and degenerated cartilage. Also, we looked at one gene
which might be involved in the re-initiation of replicative activity in osteoarthritis (OA) chondrocytes, p21WAF1/CIP1. p21WAF1/CIP1 was previously
suggested to be down-regulated in OA chondrocytes and is known to be regulated by epigenetic modulation.
Methods: Total methylation levels were analyzed by high pressure liquid chromatography (HPLC), mRNA expression of p21WAF1/CIP1 and
DNMT enzymes by real-time polymerase chain reaction. The methylation status of the p21WAF1/CIP1- promotor using bisulﬁte genomic se-
quencing was evaluated.
Results: General methylation analysis of genomic DNA showed no difference in between normal and aged/OA chondrocytes. Also no differ-
ence in methylation of the promotor of the p21WAF1/CIP1 gene was detectable, which was signiﬁcantly down-regulated in OA chondrocytes.
DNMT1 and DNMT3a were expressed with no signiﬁcant changes of expression levels found in OA chondrocytes.
Conclusion: Cell cycle progression inhibitor p21WAF1/CIP1 is expressed in normal and signiﬁcantly down-regulated in OA articular chondro-
cytes, which may mediate the re-initiation of cell proliferation in OA cartilage. However, the suppression of p21WAF1/CIP1 mRNA expression
is not due to hypermethylation of its promotor. No overall changes in genome methylation levels were found in aged or OA cartilage.
Interestingly, signiﬁcant expression of DNA methyltransferases was found in articular chondrocytes, which supports that DNA methylation
could still be a relevant mechanism of gene regulation in (osteoarthritic) chondrocytes, though not on an overall genomic level nor speciﬁcally
for the regulation of the p21WAF1/CIP1 gene.
ª 2008 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) is one of the most common disabling
diseases worldwide. OA is caused by mechanical factors,
but also a severe (dis)regulation of numerous genes impor-
tant for tissue homeostasis. Additionally, other more gen-
eral cell biological phenomena such as cell apoptosis and
proliferation play an important role in maintaining tissue in-
tegrity. The latter is related to a re-initiation of the prolifera-
tive machinery within the chondrocytes in OA cartilage1,
whereas normal articular chondrocytes are considered to
be largely post-mitotic after puberty. One important factor
involved in this particular phenotypic trait of articular chon-
drocytes may be mediated by p21WAF1/CIP1, which is known
to block proliferation in many cell types.
Clearly, one major issue during disease progression is
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507the chondrocytes. Besides gene regulation by ordinary tran-
scription factors, basic genetic and epigenetic alterations
(for review see Ikegawa2 and Roach and Aigner3) may
play an important role in determining gene expression
levels. In fact, recent experimental data indicate that differ-
ences in the methylation status within disease-relevant pro-
motors are likely to induce/repress respective gene
expressions4. This is, however, not true for all genes since
we were not able to identify changes in the methylation
levels of the aggrecan gene in aged and diseased chondro-
cytes5. At present, nothing is known about the general
methylation level in diseased chondrocytes.
Therefore, in this paper we were interested to determine
whether there is a difference in the overall methylation level
in degenerated cartilage compared to normal chondrocytes.
As we could not ﬁnd any evidence for a general hyper- or
hypomethylation we looked at one gene that might be in-
volved in the re-initiation of replicative activity in OA chon-
drocytes, p21WAF1/CIP1. p21WAF1/CIP1 was suggested to be
down-regulated in OA compared to normal chondrocytes
by previous cDNA-array analysis6. Also, p21WAF1/CIP1 ex-
pression has been previously shown in neoplastic cells to
be, at least in part, regulated by epigenetic modulation7.
508 S. Sesselmann et al.: Promotor methylation in OA chondrocytesMaterials and methodsCARTILAGE SAMPLESCartilage from normal human femoral condyles was obtained from autop-
sies within 48 h of death and processed as described previously6. Osteoar-
thritic cartilage was obtained during total knee replacement surgery.
Cartilage was considered to be normal if it showed no signiﬁcant ﬁbrilla-
tion/erosion. Only primary degenerated and not regenerative cartilage (os-
teophytic tissue) was used. For quantitative real-time polymerase chain
reaction (PCR) studies 10 samples of normal articular cartilage (48e83
years, mean 64.5 years) and 10 samples of osteoarthritic cartilage (60e83
years, mean 70.0 years) were analyzed. For bisulﬁte methodology three
samples of normal articular cartilage (52e72 years, mean 62 years) and
six samples of osteoarthritic cartilage (57e78 years, mean 67 years) were
used. For HPLC ﬁve samples of normal articular cartilage (43e72 years,
mean 53 years) and six samples of osteoarthritic cartilage (67e82 years,
mean 71 years) were analyzed.ISOLATION OF TOTAL RNA FROM CARTILAGE TISSUE e cDNA
SYNTHESIS e QUANTITATIVE REAL-TIME PCRTotal RNA was isolated from cartilage tissue and transcribed into cDNA
for real-time PCR analysis as described previously8. mRNA expression
levels were measured by real-time quantitative PCR (qPCR) using an ABI
Prism 7700 Sequence Detection System (Applied Biosystems). Primers
(MWG Biotech, Germany) and the TaqMan probe (Eurogentec, Seraing,
Belgium) were designed using the PRIMER EXPRESS software (Applied
Biosystems) (Table I). All experiments were performed in triplicates using
titrated standard curves as described elsewhere9. Glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) expression levels were used for normaliza-
tion of gene expression values. Statistical evaluation of expression levels
was calculated using the non-parametric WilcoxoneManneWhitney test.ISOLATION OF GENOMIC DNAFor isolation of genomic DNA from cartilage, tissue samples were ground
under liquid nitrogen using a freezer mill (Spex certiprep 6800) as described
previously8. Genomic DNA was isolated using the Blood and Cell culture
DNA Midi Kit in combination with the genomic DNA buffer set (Qiagen, Hil-
den, Germany).HPLC SCREENING FOR GENOMIC METHYLATION OF
CYTOSINESThe 5mdC content in genomic DNA was determined by HPLC. Residual
RNA was removed by alkaline hydrolysis with 0.5 M NaOH at 37C for 1 h.
After neutralization with HCl and DNA precipitation 10 mg DNA of each sam-
ple were digested with two units micrococcal nuclease (United States Bio-
chemical, Cleveland, USA) and 1 mg phosphodiesterase II (Roche, Basel,
Switzerland) at 37C for 3 h in 10 mM CaCl2 and 20 mM succinate at pH
6.0 according to the protocol of Young10. For complete digestion to nucleo-
sides, phosphate groups were removed by digestion with 20 units alkaline
phosphatase (Roche) after adding MgCl2 and ZnCl2 to ﬁnal concentrations
of 1 mM each and Tris (pH 8.0) to 20 mM for 16 h at 37C. Samples were
lyophylized and stored at 20C.
5mdC content was measured with a Beckmann Ultrasphere ODS column,
4.6 mm 250 mm with 5 mm pore size (Beckmann Coulter, Krefeld, Ger-
many) on a MerckeHitachi (MerckeHitachi, Amsterdam, The Netherlands)
HPLC System (L-6200 gradient pump, L-7250 autosampler and L-7450
DA-Detection System) at room temperature. After injection of the samples,
a programmed linear gradient was applied from 100% solution A (5% aceto-
nitrile with 0.04% acidic acid in H2O) to 100% solution B (100% methanol)
over 10 min at 1 ml/min. The ratio between 5mdC and dC was determined
by the ratio between the elution peak areas. All samples were measured
in triplicates.METHYLATION ANALYSIS e BISULFITE METHODFor bisulﬁte genomic sequencing 2 mg genomic DNA was bisulﬁte treated
with the EpiTec 96 Bisulﬁte Kit (Qiagen, Hilden, Germany). A 576 bp region
spanning a CpG island which includes the core promotor of the p21WAF1/CIP1
gene was ampliﬁed by the primers p21-fw (50-AGGGAAGTGTTTTTTTGTA
GT-30) and p21-rev (50-TAACCAAAAATTCCTATACTTA-30)11 [Fig. 4(a,b)].
The ampliﬁcation conditions were: 0.8 pmol/ml primers, 2.5 units AmpliTaq
Gold (Perkin Elmer, Waltham, USA), 2.5 mM MgCl2, 0.2 mM dNTPs and
buffer according to the supplier. PCR products were subcloned using the
pGEM-T Easy Vector System (Promega, Mannheim, Germany). XL1-Blue
competent cells (Stratagene, La Jolla, USA) were transformed and at least10 clones picked (from each donor) and sequenced. The methylation status
was analyzed by BIQ_Analyzer software according to Bock et al.12.ResultsGENERAL METHYLATION ANALYSIS OF THE CHONDROCYTIC
GENOMEFirst, we were interested to determine whether there was
a difference in the general methylation level of genomic
DNA in OA and normal articular chondrocytes. These anal-
yses showed no statistically signiﬁcant differences
[Fig. 1(a,b)] between OA and normal articular chondrocytes.
Also, no correlation was found with regard to the age of the
donors investigated [Fig. 1(c)].EXPRESSION ANALYSIS OF DNMT ENZYMESNext, we were interested in the expression of DNA meth-
yltransferase (DNMT) enzymes within the articular chondro-
cytes as these enzymes are the only means by which the
methylation level could increase within the cells.
Conventional PCR demonstrated the expression of all
three DNMT enzymes in normal and osteoarthritic articular
cartilage with no obvious changes in between both. Real-
time quantitative PCR conﬁrmed these results showing
that DNMT1 and DNMT3a were strongly expressed DNMTs
(both about 0.006 times GAPDH). DNMT3b was consider-
ably less expressed and hardly above background detec-
tion levels (below 0.0001/GAPDH). In OA chondrocytes
no signiﬁcant change of expression levels compared to nor-
mal was found for any of the three methylases (Fig. 2);
again DNMT3b was hardly detectable at all.EXPRESSION OF p21WAF1/CIP1 IN NORMAL AND OA CARTILAGEWe then investigated the expression levels of p21WAF1/CIP1
of articular chondrocytes in vivobyconventional PCRanalysis
of RNA isolated directly from normal articular cartilage. This
showed a strong ampliﬁcation product for p21WAF1/CIP1 in
normal articular chondrocytes [Fig. 3(a)]. The expression
levels were clearly reduced in OA cartilage cells compared
to the normal cells [Fig. 3(a)]. This was conﬁrmed by real-
time PCR, which showed a highly signiﬁcant down-regulation
in OA chondrocytes (about fourfold; P< 0.001) [Fig. 3(b)].METHYLATION ANALYSIS OF THE p21WAF1/CIP1-PROMOTOR
REGIONNext we were interested to investigate whether the ob-
served down-regulation of p21WAF1/CIP1 expression may
be due to an increased methylation grade of the
p21WAF1/CIP1-promotor region, namely the CpG island pres-
ent (for a representation of the p21WAF1/CIP1-promotor re-
gion including the CpG island see Fig. 4). Sequencing
analysis of bisulﬁte treated DNA from three normal and
six osteoarthritic donor samples showed no signiﬁcant
methylation in normal or in osteoarthritic samples.Discussion
Methylation of cytosines is an important epigenetic mech-
anism for gene regulation, essential for normal cellular func-
tions as well as genomic imprinting of speciﬁc genes such
as X chromosome inactivation in the female. A change of
the overall methylation level was suggested to be one
Table I
Sequences of primers and probes used for quantitative PCR experiments
Gene Account number Primer/probe Sequence nM* Mgy
GAPDH NM_002046 Forward 50-GAAGGTGAAGGTCGGAGTC-30 50 5.5
Reverse 50-GAAGATGGTGATGGGATTTC-30 900
Probe 50-CAAGCTTCCCGTTCTCAGCC-30 100
p21WAF1/CIP1 NM_000389 Forward 50-GCAGACCAGCATGACAGATTTC-30 300 7
Reverse 50-GCGGATTAGGGCTTCCTCTT-30 900
Probe 50-CACTCCAAACGCCGGCTGATCTTC-30 100
DNMT1 NM_001379 Forward 50-GAGGAGGGCTACCTGGCTAAA-30 300 5
Reverse 50-CGTTTTCTAGACGTCCATTCACTTC-30 300
Probe 50-CTTGGAGAACGGTGCTCATGCTTACAACC-30 100
DNMT3a NM_175629 Forward 50-CAGAAGTGCCGGAACATTGA-30 300 3
Reverse 50-TTCTTGCAGTTTTGGCACATTC-30 900
Probe 50-CCTGGAACACCCCCTCTTCGTTGG-30 100
DNMT3b NM_006892 Forward 50-GGAGTGTAATCCAGTGATGATTGATG-30 900 6
Reverse 50-ATGCTATCACGGGCCTGTTC-30 300
Probe 50-TTCTGCTGCTCACAGGGCCCGATAC-30 100
*Concentration of primer/probe in TaqMan reaction.
yMgCl2 concentration in TaqMan reaction in mM.
509Osteoarthritis and Cartilage Vol. 17, No. 4possible core mechanism of aging of cells and tissues13.
Thus, the ﬁrst important result of our study is that we
were not able to detect any signiﬁcant change in general
methylation levels in osteoarthritic and aging articular chon-
drocytes. Obviously, this does not exclude differences in
methylation levels in selected promotor regions14 asnormal
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Fig. 1. General methylation level of genomic DNA derived from normal an
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ples shown relative to the areported for some genes previously4,15,16. A caveat might
also be that measuring total DNA methylation might be
too crude to detect relevant changes in methylation levels
of relevant sites. Millions of CpG sites are located through-
out the genome, many in introns, transposons and repetitive
sequences are largely methylated. Compared to this, CpG6,0
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Fig. 2. qPCR-analysis of the expression of the DNMTs, DNMT1, DNMT3a and DNMT3b using real-time PCR (n(normal)¼ 8, n(late-osteo-
arthritic)¼ 9). Shown are values normalized to GAPDH.
510 S. Sesselmann et al.: Promotor methylation in OA chondrocytessites in the promotors of genes represent a relatively small
percentage of total CpG sites. Thus, a more focussed in-
vestigation of speciﬁc promotor CpG sites is needed. In ad-
dition, our results do not exclude major changes taking
place during childhood and adolescence, in particular as
during these life periods the organism grows. Speciﬁcally
chondrocytes also divide17 and methylation levels can in
particular be strongly modiﬁed during DNA-replication.
Thus, one potential reason for the stability in overall meth-
ylation levels in adult articular chondrocytes could be largely
related to the post-mitotic status of these cells in the adult1.
p21WAF1/CIP1 is one classical inhibitor of cell proliferation
and in fact normal non-proliferating adult chondrocytes
show a signiﬁcant expression of p21WAF1/CIP1. In contrast,
OA chondrocytes, which re-initiate cell cycle activity1, do
show a highly signiﬁcant down-regulation of p21WAF1/CIP1
expression. Thus, down-regulation of p21WAF1/CIP1 expres-
sion might well be one reason or at least one mediator of
the ‘‘de-blocking’’ of cell cycle progression in OA cartilage
cells. The reasons of this down-regulation of p21WAF1/CIP1
expression are, however, largely unclear. This current study
provides experimental evidence that no de novo methyla-
tion of the p21WAF1/CIP1-promotor-CpG island is involved
in this process, though p21WAF1/CIP1 is known to be regu-
lated by methylation, for example, in some cases of neo-
plastic transformation7,18,19. Other reports, however, could
not ﬁnd such changes of methylation pattern in the p21 pro-
motor region20. Potentially, this down-regulation of
p21WAF1/CIP1 mRNA expression might be due to a reduction
in p53 activity, of which p21WAF1/CIP1 is one direct major tar-
get gene, but no experimental data are so far available
about p53 activity in articular chondrocytes.Fig. 3. Analysis of the expression of p21WAF1/CIP1 mRNA by conventional (
samples; lane 10: Hela cell line; lane 11: water (negative control)) and rea
values normalizedMethylation of CpG sites within the genome is mediated
by enzymes known as DNMTs, namely DNMT1, DNMT3a
and DNMT3b (for review see Pradhen and Esteve21). Of
the three DNMTs, DNMT1 is responsible for maintaining es-
tablished methylation patterns during cell division. DNMT3a
and DNMT3b are known to play key roles in the de novo
methylation of primarily unmethylated DNA. In our study,
we found low, but still signiﬁcant expression levels of
DNMT1 and DNMT3a, whereas DNMT3b was hardly
expressed at all. This is similar to other adult tissues22
and in line with the assumption that DNMT3b is mostly
involved in embryonic differentiation processes. Most inter-
estingly, however, and different to other tissues is that car-
tilage is largely post-mitotic, i.e., DNMT-expression is not
needed for maintenance of methylation pattern during repli-
cation; thus, the expressed DNMTs might well be involved
in de novo methylation in articular chondrocytes. However,
so far no evidence of de novo methylation has been re-
ported in adult or OA cartilage: p21WAF1/CIP1 and aggrecan
promotors appear not to have any changes in methylation
levels at all5, other genes such as matrix metalloprotei-
nases (MMPs) and leptin appear to lose methylation during
OA progression4,15,16.
Epigenetic disregulation in OA chondrocytes is clearly
one potentially important new topic for understanding the
cellular (dis)behavior during the disease process3,23. The
implications of epigenetic alterations, namely changes in
methylation pattern, for OA are only in part investigated
so far. Important chondrocytic genes, for example collagen
type II and aggrecan, contain CpG islands in their promo-
tors, but no evidence to date exists that epigenetic alter-
ations are involved in the regulation of, for instance the
aggrecan gene in OA chondrocytes5. More relevant, Roacha: lane 1: standard; lanes 2e4: normal samples; lanes 5e9: late OA
l-time PCR (b: n(normal)¼ 10, n(late-osteoarthritic)¼ 10; shown are
to GAPDH).
Fig. 4. Analysis of p21 promoter methylation by bisulﬁte genomic sequencing. (a) Analysis of the CpG island in the p21 promoter region. (b)
A region containing 64 CpG sites was chosen for analysis. Arrows delineate the PCR product used for sequencing, individual CpG sites are
indicated by circles. (c) Ten individual alleles were analyzed for each cartilage sample (three normal, six OA). Individual alleles are arranged in
rows. Filled circles depict methylated CpG sites, open circles represent unmethylated sites. The percentage of methylated CpG sites is shown
next to each sample. ‘‘Conversion rate’’ shows the percentage of non-CpG site cytosine residues converted after bisulﬁte treatment.
511Osteoarthritis and Cartilage Vol. 17, No. 4and colleagues showed a hypomethylation of MMP-promo-
tors in OA4,16, which could be an alternative explanation for
the switch on of these matrix degrading genes than the pure
induction through inﬂammatory cytokines such as interleu-
kin-1 (IL-1). However, these changes in gene expression
appear not to be due to a general loss of methylation in
OA chondrocytes. As the human epigenome project has
shown, 88% of promotors with CpG islands are always
hypomethylated and show no correlation between DNA
methylation and gene expression at least for three chromo-
somes investigated24,25. On the other hand, methylation is
not the only epigenetic mechanism and DNA methylation
frequently synergizes with histone modiﬁcations, as thereare several examples of cancer-related genes that are
silenced by the combinatory effects of DNA methylation
and histone modiﬁcations.
In summary, in this paper we show that the cell cycle pro-
gression inhibitor p21WAF1/CIP1 is expressed in normal and
signiﬁcantly down-regulated in OA articular chondrocytes,
which may mediate the re-initiation of cell proliferation in
OA cartilage. However, the suppression of p21WAF1/CIP1
mRNA expression is not due to hypermethylation of its pro-
motor. Also, no overall changes in genome methylation
levels are found in aged or OA cartilage. Still, more
focussed studies on promotor speciﬁc methylation and
other epigenetic events in other genes could provide
512 S. Sesselmann et al.: Promotor methylation in OA chondrocytesa clue for the regulation of protein expression in the onset
and development of OA.Conﬂict of interest
The authors declare that no potential conﬂicts of interest
exist.Acknowledgments
We would like to thank Dr W. Eger (Rummelsberg, FRG) for
providing the osteoarthritic cartilage samples, Dr R. Preuss
(Erlangen, FRG) for his support conducting the HPLC mea-
surements and Mrs P. Gebhard (Leipzig, FRG) for support-
ing graphical presentation of the results. This work was
supported by the DFG (grant AI20/7-1).References
1. Aigner T, Hemmel M, Neureiter D, Gebhard PM, Zeiler G, Kirchner T,
et al. Apoptotic cell death is not a widespread phenomenon in normal
aging and osteoarthritis human articular knee cartilage: a study of pro-
liferation, programmed cell death (apoptosis), and viability of chondro-
cytes in normal and osteoarthritic human knee cartilage. Arthritis
Rheum 2001;44:1304e12.
2. Ikegawa S. New gene associations in osteoarthritis: what do they
provide, and where are we going? Curr Opin Rheumatol 2007;19:
429e34.
3. Roach HI, Aigner T. DNA methylation in osteoarthritic chondrocytes:
a new molecular target. Osteoarthritis Cartilage 2007;15:128e37.
4. Roach HI, Yamada N, Cheung KSC, Tilley S, Clarke NMP. Abnormal
expression of matrix-degrading enzymes by human osteoarthritic
chondrocytes is associated with demethylation of speciﬁc CpGs in
the promotor. Arthritis Rheum 2005;52:3110e24.
5. Po¨schl E, Fidler A, Schmidt B, Kallipolitou A, Schmid E, Aigner T. DNA-
methylation is not responsible for aggrecan down-regulation in aged
or osteoarthritic cartilage. Ann Rheum Dis 2005;64:477e80.
6. Aigner T, Zien A, Gehrsitz A, Gebhard PM, McKenna LA. Anabolic and
catabolic gene expression pattern analysis in normal versus osteoar-
thritic cartilage using complementary DNA-array technology. Arthritis
Rheum 2001;44:2777e89.
7. Fang JY, Lu YY. Effects of histone acetylation and DNA methylation on
p21(WAF1) regulation. World J Gastroenterol 2002;8:400e5.
8. McKenna LA, Gehrsitz A, Soeder S, Eger W, Kirchner T, Aigner T.
Effective isolation of high quality total RNA from human adult articular
cartilage. Anal Biochem 2000;286:80e5.9. Bau B, Gebhard PM, Haag J, Knorr T, Bartnik E, Aigner T. Relative mes-
senger RNA expression proﬁling of collagenases and aggrecanases
in human articular chondrocytes in vivo and in vitro. Arthritis Rheum
2002;46:2648e57.
10. Young JI, Smith JR. DNA methyltransferase inhibition in normal human
ﬁbroblasts induces a p21-dependent cell cycle withdrawal. J Biol
Chem 2001;276:19610e6.
11. Ying J, Srivastava G, Gao Z, Zhang X, Murray P, Ambinder R, et al. Pro-
moter hypermethylation of the cyclin-dependent kinase inhibitor
(CDKI) gene p21WAF1/CIP1/SDI1 is rare in various lymphomas and
carcinomas. Blood 2004;103:743e6.
12. Bock C, Reither S, Mikeska T, Paulsen M, Walter J, Lengauer T. BiQ
analyzer: visualization and quality control for DNA methylation data
from bisulﬁte sequencing. Bioinformatics 2005;21:4067e8.
13. Wilson VL, Jones PA. DNA methylation decreases in aging but not in
immortal cells. Science 1983;220:1055e7.
14. Szyf M. DNA methylation and cancer therapy. Drug Resist Updat 2003;
6:341e53.
15. Iliopoulos D, Malizos KN, Tsezou A. Epigenetic regulation of leptin
affects MMP-13 expression in osteoarthritic chondrocytes: possible
molecular target for osteoarthritis therapeutic intervention. Ann
Rheum Dis 2007;66:1616e21.
16. Roach HI, Inglis S, Partridge KA, Clarke NMP, Richard OC. Can
changes in the DNA methylation pattern explain the clonally inherited
altered phenotypte of osteoarthritic chondrocytes?. In: Landis W,
Sodek J, Eds. Proceedings of the 8th International Conference on
the Chemistry & Biology of Mineralized Tissues. Toronto: University
of Toronto; 2005:192e5.
17. Nilsson O, Mitchum RD, Schrier L, Barnes KM, Troendle JF, Baron J.
Growth plate senescence is associated with loss of DNA methylation.
J Endocrinol 2005;186:241e9.
18. Bott SR, Arya M, Kirby RS, Williamson M. p21WAF1/CIP1 gene is inac-
tivated in metastatic prostatic cancer cell lines by promoter methyla-
tion. Prostate Cancer Prostatic Dis 2005;8:321e6.
19. Zheng QH, Ma LW, Zhu WG, Zhang ZY, Tong TJ. p21Waf1/Cip1 plays
a critical role in modulating senescence through changes of DNA
methylation. J Cell Biochem 2006;98:1230e48.
20. Ohta T, Watanabe T, Katayama Y, Yoshino A, Yachi K, Ogino A, et al.
Aberrant promoter hypermethylation proﬁle of cell cycle regulatory
genes in malignant astrocytomas. Oncol Rep 2006;16:957e63.
21. Pradhan S, Esteve PO. Mammalian DNA (cytosine-5) methyltrans-
ferases and their expression. Clin Immunol 2003;109:6e16.
22. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J,
Gonzales FA, et al. The human DNA methyltransferases (DNMTs)
1, 3a and 3b: coordinate mRNA expression in normal tissues and
overexpression in tumors. Nucleic Acids Res 1999;27:2291e8.
23. Aigner T, Gebhard PM, Sesselmann S, So¨der S, Roach HI. DNA meth-
ylation, chondrogenesis, and cartilage degeneration. Curr Rheumatol
Rev 2006;2:221e32.
24. Brena RM, Huang TH, Plass C. Toward a human epigenome. Nat Genet
2006;38:1359e60.
25. Eckhardt F, Lewin J, Cortese R, Rakyan VK, Attwood J, Burger M, et al.
DNA methylation proﬁling of human chromosomes 6, 20 and 22. Nat
Genet 2006;38:1378e85.
